Provention Bio
+$0.05 (+1.28%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Provention Bio and other ETFs, options, and stocks.
About PRVB
Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset.
CEO
Ashleigh W. Palmer
Employees
82
Headquarters
Red Bank, New Jersey
Founded
2016
PRVB Key Statistics
Market cap
253.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
724.66K
High today
$4.06
Low today
$3.75
Open price
$4.03
Volume
643.42K
52 Week high
$11.49
52 Week low
$3.40
Analyst ratings
83%
of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
PRVB Earnings
-$0.58
-$0.39
-$0.19
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market